Gastrointestinal stromal tumor secondary prevention: Difference between revisions
Akshun Kalia (talk | contribs) No edit summary |
Akshun Kalia (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Effective measures for the secondary prevention of gastrointestinal stromal tumor include: | |||
*Regular follow ups including physical examination with laboratory and imaging evaluations. | |||
* | **GISTs are known to present with locally recurrent and distant metastasis and thus periodic evaluation through a CT scan should be done for early detection of recurrent disease. However, there is no consensus on the time interval between assessment. | ||
** | **Patients with indeterminate or inaccessible lesions can be evaluated with PET scans to identify malignant lesions from benign lesions. | ||
** | ***A positron emission tomography (PET) scanning can also be used to determine response to therapy and can identify active tumor from necrotic and inactive scar tissue. This is particularly helpful in patients receiving tyrosine kinase inhibitor therapy for incompletely resected, recurrent, or metastatic disease. | ||
* | |||
==References== | ==References== |
Revision as of 21:24, 12 December 2017
Gastrointestinal stromal tumor Microchapters |
Differentiating Gastrointestinal stromal tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Gastrointestinal stromal tumor secondary prevention On the Web |
American Roentgen Ray Society Images of Gastrointestinal stromal tumor secondary prevention |
Gastrointestinal stromal tumor secondary prevention in the news |
Blogs on Gastrointestinal stromal tumor secondary prevention |
Directions to Hospitals Treating Gastrointestinal stromal tumor |
Risk calculators and risk factors for Gastrointestinal stromal tumor secondary prevention |
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
Effective measures for the secondary prevention of gastrointestinal stromal tumor include:
- Regular follow ups including physical examination with laboratory and imaging evaluations.
- GISTs are known to present with locally recurrent and distant metastasis and thus periodic evaluation through a CT scan should be done for early detection of recurrent disease. However, there is no consensus on the time interval between assessment.
- Patients with indeterminate or inaccessible lesions can be evaluated with PET scans to identify malignant lesions from benign lesions.
- A positron emission tomography (PET) scanning can also be used to determine response to therapy and can identify active tumor from necrotic and inactive scar tissue. This is particularly helpful in patients receiving tyrosine kinase inhibitor therapy for incompletely resected, recurrent, or metastatic disease.